The World In A Grain Of Sand

The World in a Grain of Sand: CG Oncology

Listen Later

KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Cain McClary and Phil Grayeski discuss CG Oncology, the first biotech IPO of 2024. We dive into:

  • The various subtypes of bladder cancer, and one of the most unique standard of care treatment paradigms in oncology, which utilizes a live attenuated virus to treat the disease

  • Supply chain and manufacturing issues that have limited access to SoC therapy in bladder cancer 

  • CG Oncology’s lead (and only) asset, an oncolytic immunotherapy which has delivered impressive complete response data in bladder cancer

  • Challenges and open questions around complex manufacturing, clinical and commercial adoption, and competition for CG’s lead asset

  • Bull vs bear case for CG Oncology

    • For updates from KdT, ⁠⁠subscribe to our Substack⁠⁠.

    ...more
    View all episodesView all episodes
    Download on the App Store
    The World In A Grain Of SandBy KdT Ventures
    • 5
    • 5
    • 5
    • 5
    • 5

    5

    19 ratings

    More shows like The World In A Grain Of Sand

    View all
    The Bill Simmons Podcast by The Ringer

    The Bill Simmons Podcast

    30,014 Listeners

    The Long Run with Luke Timmerman by Timmerman Report

    The Long Run with Luke Timmerman

    117 Listeners

    Business Of Biotech by Matt Pillar

    Business Of Biotech

    84 Listeners